QuantLogix ← HUM scorecard
📅 HUM Earnings Preview
Humana Inc.
Next report (est.)
11/19/2026
Countdown
73 days
EPS growth YoY
+27.1%
Revenue growth YoY
+26.2%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
07/29/2026 ±3.2% -6.0% under-priced
04/29/2026 ±3.3% +5.8% under-priced
11/05/2025 ±2.9% -6.0% under-priced
07/30/2025 ±3.9% +12.4% under-priced
04/30/2025 ±3.0% +1.1% over-priced
10/30/2024 ±2.8% +3.3% under-priced
07/31/2024 ±2.8% -10.6% under-priced
04/24/2024 ±2.3% -3.7% under-priced
Across these reports, options implied an average ±3.0% move vs an actual average of 6.1% — the stock stayed inside the implied band 13% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $5.73 $40.9B $693M
Q1 FY2026 $9.83 $39.6B $1.2B
Q4 FY2025 $-6.59 $32.5B $-776M
Q3 FY2025 $1.62 $32.6B $194M
Analyst posture
Buy / Strong Buy
16
Hold
16
Sell
1
Strong upward revisions — 23 net (vs 22 prior)
Live 5-factor engine read: Strong Buy · 70/100 Full scorecard →
Get alerted before every HUM report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on HUM before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Humana Inc. (HUM) reports in 73 days, with the next report estimated for 11/19/2026. Across the last 8 reports, options priced an average ±3.0% earnings move while the stock actually moved 6.1% on average — the market has tended to under-price HUM's earnings risk. Fundamentals into the print: EPS up 27.1% year-over-year, revenue up 26.2%. QuantLogix's live 5-factor engine currently reads HUM as a strong buy at 70/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →